Method of using IL-11 for treating mucositis
AssigneeGenetics Institute, Inc.
InventorsNick W. Warne, Camille L. Bedrosian, James C. Keith, Jr., Ullrich S. Schwertschlag, Paul F. Schendel
Life of this patent
Estimating the term…
Abstract
Provided by the present invention are topical formulations of Interleukin-11 and methods for treating a variety of disorders, including inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis, indeterminate colitis, and infectious colitis), mucositis (e.g., oral mucositis, gastrointestinal mucositis, nasal mucositis, and proctitis), necrotizing enterocolitis, inflammatory skin disorders (e.g., psoriasis, atopic dermatitis, and contact hypersensitivity), aphthous ulcers, pharyngitis, esophagitis, peptic ulcers, gingivitis, periodontitis, and ocular diseases (e.g., conjunctivitis, retinitis, and uveitis).
Claims28
A method of treating mucositis in a patient, comprising administering to the patient a formulation of a pharmaceutical composition comprising a pharmaceutically effective amount of IL-11, wherein said formulation is applied at the site of inflammation in said patient.
Dependencies are inferred from the claim text.